209 related articles for article (PubMed ID: 28426731)
1. Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.
Lau HK; Wu ER; Chen MK; Hsieh MJ; Yang SF; Wang LY; Chou YE
PLoS One; 2017; 12(4):e0176246. PubMed ID: 28426731
[TBL] [Abstract][Full Text] [Related]
2. Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.
Chen CT; Lee HL; Chiou HL; Chou CH; Wang PH; Yang SF; Chou YE
PLoS One; 2018; 13(6):e0198967. PubMed ID: 29889892
[TBL] [Abstract][Full Text] [Related]
3. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
[TBL] [Abstract][Full Text] [Related]
5. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
6. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
[TBL] [Abstract][Full Text] [Related]
7. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
[TBL] [Abstract][Full Text] [Related]
8. CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Chou YE; Hsieh MJ; Hsin CH; Chiang WL; Lai YC; Lee YH; Huang SC; Yang SF; Lin CW
PLoS One; 2014; 9(4):e93692. PubMed ID: 24699672
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
10. Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.
Lin YH; Hsiao YH; Yang SF; Liu YF; Hsu CF; Wang PH
Reprod Sci; 2018 Nov; 25(11):1549-1556. PubMed ID: 29402200
[TBL] [Abstract][Full Text] [Related]
11. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
12. High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
Wang QY; Feng YJ; Ji R
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10445-10451. PubMed ID: 33155200
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
Chou CH; Chou YE; Chuang CY; Yang SF; Lin CW
PLoS One; 2017; 12(2):e0171583. PubMed ID: 28152093
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells.
Chuang JY; Chang AC; Chiang IP; Tsai MH; Tang CH
PLoS One; 2013; 8(10):e78022. PubMed ID: 24205072
[TBL] [Abstract][Full Text] [Related]
15. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
[TBL] [Abstract][Full Text] [Related]
16. Identification of WISP1 as a novel oncogene in glioblastoma.
Jing D; Zhang Q; Yu H; Zhao Y; Shen L
Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
[TBL] [Abstract][Full Text] [Related]
17. Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.
Chen J; Yin JY; Li XP; Wang Y; Zheng Y; Qian CY; He H; Fang C; Wang Z; Zhang Y; Xiao L; Wang SY; Zhang W; Zhou HH; Liu ZQ
Clin Lung Cancer; 2015 Jul; 16(4):298-304.e1-2. PubMed ID: 25656821
[TBL] [Abstract][Full Text] [Related]
18. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
Gurbuz I; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
[TBL] [Abstract][Full Text] [Related]
19. WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.
Chen J; Yin J; Li X; Wang Y; Zheng Y; Qian C; Xiao L; Zou T; Wang Z; Liu J; Zhang W; Zhou H; Liu Z
Int J Mol Sci; 2014 Nov; 15(11):21011-27. PubMed ID: 25405734
[TBL] [Abstract][Full Text] [Related]
20. WNT1-inducible signaling pathway protein 1 contributes to ventilator-induced lung injury.
Li HH; Li Q; Liu P; Liu Y; Li J; Wasserloos K; Chao W; You M; Oury TD; Chhinder S; Hackam DJ; Billiar TR; Leikauf GD; Pitt BR; Zhang LM
Am J Respir Cell Mol Biol; 2012 Oct; 47(4):528-35. PubMed ID: 22700866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
